| http://www.w3.org/ns/prov#value | - Since age is a risk factor for the cardiotoxicity of trastuzumab, and women ??? 65 years were under-represented in trastuzumab clinical trials, determination of the safety and efficacy of trastuzumab in this patient population is lacking.
|
